PFPG
AXSM icon

Pinnacle Financial Partners (Georgia)’s Axsome Therapeutics AXSM Stock Holding History

Pinnacle Financial Partners (Georgia)’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.59M Sell
22,842
-23
-0.1% -$4.99K 0.04% 302
2026
Q1 		$3.86M Buy
22,865
+126
+0.6% +$21.8K 0.03% 345
2025
Q4 		$4.15M Buy
+22,739
New +$3.17M 0.03% 325

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Pinnacle Financial Partners (Georgia)'s AXSM Position: Q2 2026 in Review

Pinnacle Financial Partners (Georgia) reduced its Axsome Therapeutics (AXSM) stake by 0.1% in Q2 2026, selling an estimated $4.99K and leaving 22,842 shares worth $5.59M. The position accounts for 0.04% of the portfolio, ranked #302.

Pinnacle Financial Partners (Georgia) first reported a position in AXSM in Q4 2025 and has held it in 3 quarters since. 504 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Pinnacle Financial Partners (Georgia) held 22,842 shares of Axsome Therapeutics worth $5.59M as of Q2 2026.
  • Pinnacle Financial Partners (Georgia) sold 23 Axsome Therapeutics shares in Q2 2026, an estimated $4.99K.
  • Axsome Therapeutics made up 0.04% of Pinnacle Financial Partners (Georgia)'s portfolio in Q2 2026, its #302 holding.
  • Pinnacle Financial Partners (Georgia) first reported a position in Axsome Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 504 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Pinnacle Financial Partners (Georgia)'s 13F filing for Q2 2026, filed 14 Aug 2026.